Gossamer Bio, Inc.
GOSS
$0.16
-$0.02-11.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 136.22% | 1.22% | 2.04% | -25.99% | -4.46% |
| Total Depreciation and Amortization | 8.62% | 2.20% | 3.18% | 3.29% | -37.72% |
| Total Amortization of Deferred Charges | 1,843.14% | 1.59% | 1.21% | 1.22% | 1.66% |
| Total Other Non-Cash Items | -941.42% | 211.82% | -78.85% | 1,232.87% | 345.04% |
| Change in Net Operating Assets | -874.89% | 153.86% | -211.06% | 130.63% | -190.23% |
| Cash from Operations | -1.82% | 19.86% | -33.59% | 23.15% | -18.47% |
| Capital Expenditure | -- | -- | -- | 100.00% | -103.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.63% | -43.13% | 329.98% | -61.49% | 100.01% |
| Cash from Investing | 2.63% | -43.13% | 329.98% | -61.44% | 100.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -87.05% | 111.27% | 1,891.49% | -81.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -714.06% | -87.05% | 111.27% | 1,891.49% | -81.35% |
| Foreign Exchange rate Adjustments | 88.12% | -5,150.00% | 102.11% | -173.64% | 22.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.36% | -88.56% | 265.74% | -540.71% | 84.10% |